Introduction

Neurofibromatosis (NF) is a condition you are born with that affects your nervous system, causing tumours to grow on your nerves.^1,2 NF is typically a non-cancerous condition that can cause a wide range of symptoms; sometimes, your symptoms are obvious right away, or they can develop very gradually over time. Symptoms often include skin changes such as brown birthmarks (called café-au-lait spots) and soft tumours either on top of or under your skin birthmarks (called neurofibromas).³ Other skin changes can include small clusters of freckles under your armpits and issues with your bones or eyes.

NF1 is often associated with learning difficulties.¹ There are different types of NF, including NF1, the most common type, as well as NF2, and Schwannomatosis.³ NF is normally diagnosed through a combination of clinical examination, imaging techniques like an MRI scan, genetic testing, blood tests, and sometimes by taking a skin biopsy.^1,2 People with NF will need to be regularly monitored by their doctor to prevent any complications and to treat any symptoms as they arise.

Characteristic signs and symptoms

Skin

• A minimum of six brown birthmarks (called café au lait spots) roughly 5mm in diameter²
• Clusters of freckles under your armpits, around your groin, or over your breast area¹
• Pea-sized, painless tumours on or under your skin (called neurofibromas)^1,4

Behaviour

• Attention deficit hyperactivity disorder (ADHD) affects around half of all children with NF1¹
• Autism spectrum disorder (ASD)
• Difficulties with social communication in children⁴

Eyes

• Blurry vision³
• Changes in colour perception
• A narrower field of vision
• One eye being slightly larger than the other¹

Physical development

• Curvature of the spine (scoliosis)²
• A large head, occurs in 50% of children¹
• Low body weight³

Nervous system

• Migraines
• Personality changes
• Weakness on one side of the body
• Poor balance
• Poor hand-eye-coordination¹

Clinical Diagnosis

Diagnosing neurofibromatosis (NF) involves a multi-faceted approach due to its diverse manifestations and genetic complexity.² Clinical diagnosis often begins with a thorough physical examination, where characteristic signs such as café-au-lait spots, skin neurofibromas, and other abnormalities are observed. Medical professionals use established diagnostic criteria, such as the National Institutes of Health (NIH) criteria for NF1 and the Manchester criteria for NF2, to aid in diagnosis.^2,3

Diagnosing NF in adults and older teenagers is usually faster as the typical symptoms are often most obvious at this stage. On the contrary, diagnosing NF in children can take some time since the symptoms may take years to develop, and up to 5% of children who test negatively for NF on a blood test can still grow up to develop the condition.¹

Medical imaging

Imaging techniques are crucial in confirming and characterising NF-related tumours and abnormalities. Magnetic Resonance Imaging (MRI) is particularly valuable for assessing central nervous system involvement, while ultrasound may be used for superficial lesions and prenatal diagnosis.⁴ MRI is a pivotal tool in diagnosing NF due to its ability to provide detailed images of soft tissues, including the brain, spinal cord, and nerves.

MRI plays a crucial role in assessing the extent and characteristics of NF-related tumours and abnormalities, aiding in both diagnosis and treatment planning. In NF1, MRI is used to detect and monitor the growth of neurofibromas, which are benign tumours arising from peripheral nerves.^3,4 These tumours can vary in size and location, and MRI helps in visualising their precise anatomical location and any associated complications such as compression of nearby structures or spinal cord involvement.

Additionally, MRI can identify other NF-related manifestations such as optic gliomas, which are tumours affecting the optic nerves.^3,4 In NF2, MRI is essential for identifying bilateral vestibular schwannomas, which are tumours that develop on the nerves responsible for balance and hearing. MRI allows for early detection and monitoring of these tumours, which is critical for preserving hearing function and managing associated symptoms.

Advanced MRI techniques, such as diffusion-weighted imaging (DWI) and functional MRI (fMRI), offer additional insights into the microstructural and functional changes associated with NF-related lesions. These techniques can help differentiate between benign and malignant tumours, assess tumour vascularity, and predict treatment response.

Ongoing advancements in MRI technology continue to enhance its diagnostic capabilities, contributing to improved outcomes for patients with NF. Computed Tomography (CT) scans, though less commonly used, have specific applications in certain scenarios.³

Genetic testing

Genetic testing has become increasingly integral in diagnosing NF, particularly for confirming the presence of NF1 and NF2 gene mutations. Molecular genetic testing and next-generation sequencing techniques have enhanced diagnostic accuracy and facilitated genetic counselling for affected individuals and their families. Genetic testing has revolutionized the diagnosis and management of neurofibromatosis (NF) by enabling precise identification of underlying genetic mutations associated with NF1 and NF2.³

Molecular genetic testing

This approach involves analysing DNA extracted from a blood sample to identify specific mutations in the NF1 or NF2 genes. Genetic testing can confirm a clinical diagnosis, especially in cases where symptoms are ambiguous or where there is a family history of NF. It also allows for predictive testing in at-risk family members, aiding in genetic counselling and family planning decisions.

Next-Generation sequencing (NGS)

NGS technologies have significantly advanced the efficiency and accuracy of genetic testing for NF. These techniques enable the simultaneous analysis of multiple genes associated with NF and other related conditions, allowing for comprehensive genetic screening in a single test. NGS can identify rare or novel mutations that may not be detected by traditional sequencing methods, enhancing diagnostic sensitivity and specificity.⁵

Variant classification

Genetic testing results are interpreted and classified into different categories based on their clinical significance. Variants are classified as pathogenic, likely pathogenic, benign, likely benign, or variants of uncertain significance (VUS). Variant classification plays a crucial role in determining disease risk, guiding clinical management decisions, and providing accurate genetic counselling to affected individuals and their families.^4,5

Genetic counselling

Genetic counselling is an essential component of genetic testing for NF, providing individuals and families with information about the inheritance pattern, implications of test results, and available management options. Genetic counsellors help individuals make informed decisions about genetic testing, family planning, and screening recommendations based on their personal and familial risk factors.⁵

Other kinds of testing

In some cases, biopsy and histopathological examination may be necessary to confirm a diagnosis, especially when imaging and genetic testing results are inconclusive or when there is suspicion of malignant transformation. Despite the challenges posed by NF's variability and complexity, advances in diagnostic methods continue to improve early detection and management, offering hope for better outcomes for individuals affected by this condition.

Summary

Diagnosing NF involves a comprehensive approach encompassing clinical examination, imaging techniques like MRI, genetic testing, and sometimes a skin biopsy. Clinicians rely on established criteria, such as the NIH criteria for NF1 and the Manchester criteria for NF2, to aid diagnosis. Imaging, particularly MRI, provides detailed insights into NF-related tumours and abnormalities in the nervous system, aiding in early detection and treatment planning.

Genetic testing plays a pivotal role in confirming NF diagnosis, identifying specific gene mutations, and offering valuable information for genetic counselling and family planning. Biopsy and histopathological examination may be necessary to confirm diagnosis and assess any unusual tumour characteristics. Despite the challenges posed by NF's variability, advances in diagnostic methods continue to enhance early detection and management, offering hope for improved outcomes for individuals affected by this condition.